The purpose of the Clinical Trials Watch is to provide accessible and up-to-date information on clinical trials (i.e. studies) that are investigating drugs for Alzheimer’s disease and/or dementia. We hope that this information is useful to affected people, their families, carers and anyone with an interest in dementia research.
Alzheimer Europe's Clinical Trials Watch database was developed as part of the 2018 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).
Alzheimer Europe gratefully acknowledges the support of its corporate sponsors for the update and maintenance of the database.